查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011617

远端心臟监测设备市场：按设备类型、连接方式、适应症、最终用户和分销管道划分－全球市场预测（2026-2032 年）

Remote Cardiac Monitoring Devices Market by Device Type, Connectivity Type, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，远端心臟监测设备市场价值将达到 16.3 亿美元，到 2026 年将成长至 18.7 亿美元，到 2032 年将达到 48.2 亿美元，复合年增长率为 16.74%。

主要市场统计数据
基准年（2025 年） 16.3亿美元
预计年份（2026年） 18.7亿美元
预测年份（2032年） 48.2亿美元
复合年增长率（） 16.74%

不断发展的感测器技术、智慧软体和临床部署趋势如何重新定义长期心臟护理和市场动态？

远端心臟监测领域已超越了简单的遥测技术，发展成为一个涵盖植入式、非穿戴式和穿戴式技术的复杂生态系统，共同重塑长期心臟照护的模式。临床医生越来越依赖连续和间歇性监测工具来弥补诊断缺口、优化治疗方案调整併减少不必要的住院。同时，医疗设备製造商、软体供应商和保险公司也正在应对监管审查、互通性要求以及不断变化的报销机制，这些因素都影响着产品设计和商业策略。

技术、监管和医疗保健服务的关键转折点将推动远端心电图监测在所有相关人员。

多项变革正在重塑远距心臟监测的格局，改变临床医生检测心律不整、管理心臟衰竭以及提供大规模预防性护理的方式。首先，从间歇性监测转向连续性监测，使得人们更需要能够在较长时间内提供可靠数据并最大限度减轻患者负担的设备。这项进步透过支持早期发现具有临床意义的事件并实现远距治疗协调，从而增强了护理的连续性。

关税带来的供应链重组和对成本透明度的要求，正在重新思考心臟监测设备的采购、製造和购买策略。

2025年实施的关税政策给在国际供应链中运营的製造商和经销商带来了新的挑战，影响远端心电图监测解决方案的零件采购、製造地和定价策略。某些医疗设备零件和电子子系统的关税提高，迫使采购团队重新评估与供应商的关係，并加快将製造地多元化，转移到贸易条件更有利的地区。

产品设计重点在于使特定细分市场的部署模式与设备的侵入性、连接选项、临床适应症、医疗保健环境和分销模式保持一致。

透过按设备、连接方式、临床适应症、最终用户和分销管道进行细分，我们获得了不同的洞察，揭示了不同的部署趋势和投资重点。根据设备类型，该生态系统涵盖植入式、非穿戴式和穿戴式三大类。植入式设备包括植入式心臟监视器和远端心律调节系统，可提供长期心率监测和治疗整合。非穿戴式装置包括心臟事件记录器和心电图监测，可提供短期诊断简介。穿戴式装置包括胸带、贴片式监视器和腕式监视器，强调便利性和病患参与度。如此广泛的选择凸显了侵入性、数据连续性和临床细节之间的权衡，相关人员在将产品系列与治疗路径相匹配时必须仔细考虑这些因素。

区域间监管环境、支付方期望和基础设施发展的差异如何影响全球市场进入和业务扩大策略？

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的采纳路径、监管预期和商业化策略都有显着影响。在美洲，医疗保健系统日益关注基于价值的医疗结果和大规模化部署能力，因此对能够降低医疗成本并与人群健康管理平台整合的监测解决方案的需求日益增长。在此背景下，全面的临床证据和可扩展的支援服务对于临床医生广泛采纳这些解决方案至关重要。

透过临床证据、互通平台、灵活的製造能力和以结果为导向的经营模式。

远距心电图监测领域的竞争日益集中于整合价值提案，这些主张融合了检验的硬体、临床透明的演算法和稳健的服务模式。领先的参与企业优先考虑长期临床检验，投资于前瞻性研究和真实世界数据（REW），以支持其在诊断准确性、治疗优化和避免住院方面的说法。同时，在软体和云端服务方面拥有优势的参与企业正与设备製造商合作，加速临床工作流程的部署，并建立端到端解决方案，透过订阅模式实现持续的收入来源。

高阶管理层必须采取关键行动，将设备创新转化为可持续的临床部署、支付方的接受度和强劲的商业性成长。

产业领导者应优先采取一系列策略行动，将技术能力转化为永续的临床和商业性影响。首先，投资严格的临床检验，将医疗设备的效能指标与有意义的治疗结果和病患的健康经济价值连结起来。这将有助于企业加强与保险公司的对话，并促进具有影响力的临床医生群体采纳相关技术，从而更好地制定临床指南。其次，从一开始就注重互通性设计，最大限度地减少医疗系统中采用这些技术的障碍，确保设备和平台能够与电子健康记录、远端医疗系统和人群健康管理工具无缝整合。

采用透明的混合方法研究途径，结合相关人员访谈、技术整合和比较分析，检验了对设备和市场的洞察。

本分析所依据的研究结合了定性和定量方法，旨在揭示技术进步、监管趋势和相关人员的行为。主要调查包括对临床医生、采购经理、监管专家和分销合作伙伴进行结构化访谈，以确定推动产品采用的因素、整合挑战和证据偏好。次要调查整合了同行评审的临床文献、监管指导文件和供应商技术规范，以支援有关设备功能、连接性和可验证临床结果的声明。

从综合策略观点创新、证据产生和供应链韧性如何整合，从而定义远距心电图监测领域的领导地位。

总而言之，远距心电图监测正处于一个转折点，感测、连接和分析技术的进步与不断发展的医疗模式和支付方的期望交汇融合。这促成了一个市场的形成，在这个市场中，那些展现出临床获益、操作互通性和明确经济价值的整合解决方案备受重视。儘管不断变化的收费系统和区域监管差异带来了复杂性，但也奖励稳健的供应链和切实可行的商业化策略的形成，从而促进更广泛的应用。

目录

第一章 引言

第二章 分析方法

  • 分析设计
  • 分析框架
  • 市场规模预测
  • 数据三角测量
  • 分析结果
  • 分析的前提条件
  • 分析的局限性

第三章执行摘要

  • 首席体验长的观点
  • 市场规模和成长趋势
  • 市占率分析（2025 年）
  • FPNV定位矩阵（2025）
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入（GTM）策略

第五章 市场洞察

  • 消费者分析与最终用户观点
  • 消费者体验基准测试
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第六章：美国关税的累积影响（2025 年）

第七章：人工智慧（AI）的累积影响（2025 年）

第八章 远端心臟监测设备市场：依设备类型划分

  • 嵌入式
    • 植入式心臟监测器
    • 远端心律调节器系统
  • 不可穿戴
    • 心臟事件记录器
    • 心电图监测
  • 穿戴式装置
    • 胸带
    • 贴片式监视器
    • 腕式显示器

第九章：远端心臟监测设备市场：依连接方式划分

  • Bluetooth
  • 细胞
  • Wi-Fi

第十章：远距心臟监测设备市场：依适应症划分

  • 心律不整检测
  • 心电图监测
  • 心臟衰竭监测

第十一章 远端心臟监测设备市场：依最终用户划分

  • 门诊部
  • 诊断检查室
  • 居家医疗
  • 医院

第十二章 远端心臟监测设备市场：依通路划分

  • 在线的
  • 离线

第十三章 远端心臟监测设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 远端心臟监测设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 远端心臟监测设备市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国远距心臟监测设备市场

第十七章：中国远距心臟监测设备市场

第十八章 竞争格局

  • 市场集中度分析（2025 年）
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析（2025 年）
  • 产品系列分析（2025 年）
  • 基准分析（2025 年）
  • Abbott Laboratories
  • AliveCor, Inc.
  • Asahi Kasei Corporation
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Eko Health, Inc.
  • GE Healthcare
  • Hill-Rom Holdings, Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Nihon Kohden Corporation
  • Preventice Solutions, LLC
  • Qardio, Inc.
  • Schiller AG
  • ScottCare Corporation
  • VivaLNK, Inc.
Product Code: MRR-43676CF42329

The Remote Cardiac Monitoring Devices Market was valued at USD 1.63 billion in 2025 and is projected to grow to USD 1.87 billion in 2026, with a CAGR of 16.74%, reaching USD 4.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.63 billion
Estimated Year [2026] USD 1.87 billion
Forecast Year [2032] USD 4.82 billion
CAGR (%) 16.74%

How evolving sensor innovation, software intelligence, and clinical adoption patterns are redefining longitudinal cardiac care and commercial dynamics

The landscape for remote cardiac monitoring has matured beyond simple telemetry; it now encompasses a complex ecosystem of implantable, non-wearable, and wearable technologies that together redefine longitudinal cardiac care. Clinicians increasingly rely on continuous and episodic monitoring tools to close diagnostic gaps, optimize therapy titration, and reduce avoidable hospital admissions. At the same time, device manufacturers, software vendors, and payers are navigating regulatory scrutiny, interoperability expectations, and evolving reimbursement pathways that shape product design and commercial strategies.

Technological advances in sensor miniaturization, battery longevity, and signal fidelity have enabled monitoring solutions to transition from episodic snapshots to persistent, clinically actionable datasets. Concurrently, remote patient management platforms now combine automated algorithms with clinician dashboards to triage events, prioritize interventions, and integrate findings into electronic health records. These capabilities are driving adoption among cardiology practices, electrophysiology labs, and value-based care programs where longitudinal insight into arrhythmia burden and heart failure status can materially influence outcomes.

The introduction of software-driven diagnostics and analytics has also shifted competitive dynamics. Companies that pair robust hardware with validated, explainable algorithms and secure, standards-based connectivity architectures are positioned to capture clinical trust and payer recognition. Looking ahead, the interplay between clinical utility, ease of use, and economic evidence will determine which innovations scale from pilot deployments to standard clinical pathways.

Key technological, regulatory, and care-delivery inflection points driving accelerated adoption and strategic repositioning across remote cardiac monitoring stakeholders

Several transformative shifts are reshaping the remote cardiac monitoring landscape, altering how clinicians detect arrhythmias, manage heart failure, and deliver preventive care at scale. First, the migration from episodic to continuous monitoring has intensified demand for devices that provide reliable data over extended periods while minimizing patient burden. This progression supports earlier detection of clinically significant events and enables remote titration of therapies, thereby enhancing care continuity.

Second, connectivity and interoperability have become non-negotiable. Devices that seamlessly transmit data through cellular, Bluetooth, or Wi Fi channels into secure cloud environments enable real-time clinician review and integration with electronic health records. These connections also facilitate software updates, remote troubleshooting, and the deployment of new analytic models, which prolongs device relevance and improves lifecycle economics.

Third, regulatory frameworks and reimbursement models are evolving in tandem with technology, encouraging evidence generation and real-world validation of clinical benefit. Payers and health systems increasingly demand demonstrable outcomes such as reduced readmissions or improved guideline-directed therapy adherence, which drives manufacturers to invest in clinical studies and health economic models. Finally, patient expectations and the shift toward decentralized care have elevated the importance of usability, data privacy, and transparent value communication, compelling stakeholders to prioritize human-centered design and robust security practices.

Tariff-driven supply chain reconfiguration and cost transparency imperatives reshaping sourcing, manufacturing, and procurement strategies for cardiac monitoring devices

Tariff policies enacted in 2025 have introduced a layer of complexity for manufacturers and distributors operating across international supply chains, affecting component sourcing, manufacturing footprints, and pricing strategies for remote cardiac monitoring solutions. Increased duties on certain medical device components and electronic subsystems have prompted procurement teams to reassess supplier relationships and accelerate diversification of manufacturing sites to jurisdictions with more favorable trade terms.

In response, several device makers have implemented nearshoring or regionalization strategies to mitigate tariff exposure and reduce lead times. These moves have implications for inventory management, quality control processes, and regulatory filings, especially where manufacturing changes necessitate new conformity assessments or supplemental regulatory submissions. Additionally, distributors and health systems have reacted by scrutinizing total landed costs, which include tariffs, freight, and compliance overhead, thereby influencing purchasing decisions and contract negotiations.

The tariff-induced cost pressure has also catalyzed innovation in product design with an emphasis on modularity and component standardization to enable greater flexibility in sourcing. While tariffs have introduced short-term supply chain disruption for some market participants, the resulting strategic responses are accelerating supply chain resilience and prompting renewed focus on lifecycle cost transparency across procurement organizations.

Segment-driven adoption patterns and product design priorities that align device invasiveness, connectivity choices, clinical indications, care settings, and distribution models

Insights drawn from device, connectivity, clinical indication, end-user, and distribution channel segmentation reveal differentiated adoption dynamics and investment priorities. Based on device type, the ecosystem spans implantable, non-wearable, and wearable categories, with implantable options such as insertable cardiac monitors and remote pacemaker systems offering prolonged cardiac rhythm surveillance and therapy integration, non-wearable solutions including event monitors and Holter recorders delivering short-term diagnostic snapshots, and wearables like chest straps, patch monitors, and wrist monitors emphasizing convenience and patient engagement. This spectrum highlights a trade-off between invasiveness, data continuity, and clinical granularity that stakeholders must balance when aligning product portfolios to care pathways.

Regarding connectivity type, Bluetooth, cellular, and Wi Fi each present unique implications for battery life, data latency, and deployment logistics, which in turn influence clinical workflows and patient onboarding. Bluetooth-enabled devices often favor integration with smartphones for local telemetry, cellular connectivity supports direct cloud transmission without patient tethering, and Wi Fi can offer cost-effective high-throughput sessions in home or institutional settings. Clinical indication segmentation into arrhythmia detection, ECG monitoring, and heart failure monitoring reveals divergent data requirements and analytic approaches, necessitating tailored algorithm validation and clinician-facing visualizations to support distinct decision points.

Examining end-user segmentation among ambulatory care centers, diagnostic laboratories, home care, and hospitals underscores the need for adaptable solutions that scale across settings of care. Each end-user brings different technical infrastructures, reimbursement considerations, and clinical staffing models, so product design and services must accommodate variable integration complexity and support demands. Finally, distribution channel dynamics, whether through direct sales or distributors, affect market reach, customer education, and after-sales support, shaping commercial models and partnership strategies for companies seeking to penetrate diverse healthcare systems.

How divergent regional regulatory landscapes, payer expectations, and infrastructure readiness shape differentiated market entry and scaling strategies globally

Regional dynamics exert a strong influence on adoption pathways, regulatory expectations, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, health systems emphasize value-based outcomes and large-scale deployment capabilities, creating demand for monitoring solutions that demonstrate cost-of-care reductions and integration with population health platforms. This environment favors comprehensive clinical evidence and scalable support services to enable widespread clinician adoption.

Within Europe, Middle East & Africa, regulatory harmonization efforts and diverse payer landscapes require nuanced market entry strategies that address country-specific reimbursement criteria and local clinical guidelines. Stakeholders operating here must balance central European regulatory expectations with the variability of national coverage decisions, while also attending to infrastructure disparities that affect remote monitoring rollouts. The Asia-Pacific region presents a mix of rapid digital health adoption in some markets alongside resource-constrained settings in others, driving a bifurcated approach where high-end, feature-rich devices coexist with cost-effective, simplified monitoring solutions tailored for broader access.

Across all regions, localization of connectivity solutions, data residency considerations, and adherence to regional privacy standards are critical. Consequently, companies pursuing global expansion should adopt modular go-to-market strategies that accommodate regional regulatory timelines, distribution ecosystems, and payer engagement models to optimize adoption and long-term sustainability.

Competitive differentiation through clinical evidence, interoperable platforms, flexible manufacturing, and outcome-linked commercial models

Competitive activity in the remote cardiac monitoring sector increasingly centers on integrated value propositions that combine validated hardware, clinically transparent algorithms, and robust service models. Leading entrants prioritize long-term clinical validation, investing in prospective studies and real-world evidence to substantiate claims related to diagnostic yield, therapy optimization, and hospitalization avoidance. At the same time, entrants with strengths in software and cloud services seek to partner with device manufacturers to create end-to-end solutions that accelerate clinical workflow adoption and enable recurring revenue streams through subscription models.

Strategic differentiation also arises from supply chain and manufacturing capabilities. Firms that maintain flexible production footprints and strong component sourcing relationships can respond more rapidly to regulatory changes and tariff-induced disruptions. Moreover, companies that emphasize interoperability-adopting open standards for data exchange and APIs-tend to achieve broader clinical integration and attract health systems that value vendor-neutral platforms. Finally, business model innovation, including outcome-based contracting and bundled care solutions, is becoming an important avenue for translating clinical effectiveness into commercial advantage, particularly in markets with value-based payment frameworks.

Actionable imperatives for executives to translate device innovation into sustained clinical adoption, payer acceptance, and resilient commercial growth

Industry leaders should prioritize a set of strategic actions to convert technological capability into sustained clinical and commercial impact. First, invest in rigorous clinical validation that aligns device performance metrics with meaningful patient outcomes and health economic value. By doing so, organizations can strengthen payer dialogues and facilitate adoption among guideline-influencing clinician groups. Second, design for interoperability from the outset so that devices and platforms can integrate seamlessly with electronic health records, telehealth systems, and population health tools, thereby minimizing implementation friction for health systems.

Third, build resilient supply chains through geographic diversification of manufacturing and component sourcing to reduce exposure to tariffs and logistical bottlenecks. Fourth, adopt patient-centered design principles that lower barriers to use, including simplified onboarding, clear privacy communication, and long battery life, which together boost adherence and data completeness. Fifth, explore flexible commercial constructs such as outcome-based agreements and bundled offerings that align financial incentives with clinical value and can accelerate payer acceptance. Collectively, these actions will enable organizations to move from product-led tactics to platform-led strategies that capture recurring revenue and deepen clinical integration.

Transparent, mixed-methods research approach combining stakeholder interviews, technical synthesis, and comparative analysis to validate device and market insights

The research underpinning this analysis combined qualitative and quantitative approaches to map technology trajectories, regulatory developments, and stakeholder behaviors. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and distribution partners to surface adoption drivers, integration challenges, and evidence preferences. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance documents, and vendor technical specifications to corroborate claims about device capabilities, connectivity modalities, and demonstrable clinical outcomes.

Analytical methods incorporated comparative product analyses, supply chain risk assessment, and thematic coding of stakeholder interviews to identify common barriers and success factors. Cross-validation steps included triangulating interview findings with public filings and technical white papers to ensure factual coherence. Limitations of the methodology included variability in published clinical evidence maturity across device categories and the continual evolution of connectivity standards, both of which were addressed through sensitivity checks and engagement with multiple market actors to achieve a balanced perspective.

Consolidated strategic perspective on how innovation, evidence generation, and supply chain resilience converge to define leadership in remote cardiac monitoring

In summary, remote cardiac monitoring stands at an inflection point where advances in sensing, connectivity, and analytics are converging with shifting care models and payer expectations. The net effect is a marketplace that rewards integrated solutions demonstrating clinical benefit, operational interoperability, and clear economic value. While tariff changes and regional regulatory divergence introduce complexity, they also incentivize resilient supply chains and pragmatic commercialization strategies that can unlock broader adoption.

Decision-makers should view the current environment as an opportunity to refine product portfolios, invest in clinical evidence, and pursue partnerships that expand reach across care settings. Ultimately, the organizations that align technology development with clinician workflows, prioritize patient usability, and construct compelling value propositions for payers will be best positioned to lead the next phase of remote cardiac care evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Remote Cardiac Monitoring Devices Market, by Device Type

  • 8.1. Implantable
    • 8.1.1. Insertable Cardiac Monitor
    • 8.1.2. Remote Pacemaker System
  • 8.2. Non Wearable
    • 8.2.1. Event Monitor
    • 8.2.2. Holter Recorder
  • 8.3. Wearable
    • 8.3.1. Chest Strap
    • 8.3.2. Patch Monitor
    • 8.3.3. Wrist Monitor

9. Remote Cardiac Monitoring Devices Market, by Connectivity Type

  • 9.1. Bluetooth
  • 9.2. Cellular
  • 9.3. Wi Fi

10. Remote Cardiac Monitoring Devices Market, by Indication

  • 10.1. Arrhythmia Detection
  • 10.2. ECG Monitoring
  • 10.3. Heart Failure Monitoring

11. Remote Cardiac Monitoring Devices Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Care
  • 11.4. Hospitals

12. Remote Cardiac Monitoring Devices Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Remote Cardiac Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Remote Cardiac Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Remote Cardiac Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Remote Cardiac Monitoring Devices Market

17. China Remote Cardiac Monitoring Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AliveCor, Inc.
  • 18.7. Asahi Kasei Corporation
  • 18.8. BioTelemetry, Inc.
  • 18.9. Biotronik SE & Co. KG
  • 18.10. Boston Scientific Corporation
  • 18.11. Eko Health, Inc.
  • 18.12. GE Healthcare
  • 18.13. Hill-Rom Holdings, Inc.
  • 18.14. iRhythm Technologies, Inc.
  • 18.15. Koninklijke Philips N.V.
  • 18.16. Medtronic plc
  • 18.17. Nihon Kohden Corporation
  • 18.18. Preventice Solutions, LLC
  • 18.19. Qardio, Inc.
  • 18.20. Schiller AG
  • 18.21. ScottCare Corporation
  • 18.22. VivaLNK, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INSERTABLE CARDIAC MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INSERTABLE CARDIAC MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INSERTABLE CARDIAC MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY REMOTE PACEMAKER SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY REMOTE PACEMAKER SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY REMOTE PACEMAKER SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY EVENT MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY EVENT MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY EVENT MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOLTER RECORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOLTER RECORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOLTER RECORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CHEST STRAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CHEST STRAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CHEST STRAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY PATCH MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY PATCH MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY PATCH MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WRIST MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WRIST MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WRIST MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ARRHYTHMIA DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ARRHYTHMIA DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ARRHYTHMIA DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ECG MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ECG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ECG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HEART FAILURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HEART FAILURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HEART FAILURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 166. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 193. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. G7 REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA REMOTE CARDIAC MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)